ArticleInternational journal of chronic obstructive pulmonary disease2026
Genetic Architecture of Comorbidity Between Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: Exploring Shared Mechanisms and Potential Therapeutic Targets.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi‑feature Prediction Model for Coronary Heart Disease Comorbidity in Middle‑aged and Older Adults with COPD Based on Machine Learning and SHAP.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVDs), including hypertension (HTN), coronary heart disease (CHD), and heart failure (HF), are major global health burdens. The shared genetic mechanisms underlying the high comorbidity between COPD and CVDs remain unclear. Methods: We integrated large-scale GWAS summary statistics for COPD and three major CVDs (HTN, CHD, HF). Several analytic approaches were applied, including linkage disequilibrium score regression (LDSC), high-definition likelihood (HDL), multi-marker analysis of genomic annotation (MAGMA), pleiotropic analysis under composite null hypothesis (PLACO), and summary-data-based Mendelian randomization (SMR). These methods were used to evaluate genetic correlations, identify shared risk loci, and prioritize potential therapeutic targets. Results: LDSC and HDL analyses revealed significant positive genetic correlations between COPD and the three CVDs (rg = 0.23-0.38, P < 0.05). MAGMA enrichment analysis identified 277 unique pleiotropic genes enriched in pathways such as Notch signaling and nicotinic acetylcholine receptor signaling. Tissue-specific analyses indicated that shared genetic signals were enriched not only in the lung and heart but also in neuroendocrine-related tissues such as the cerebellum and pituitary, suggesting the involvement of a potential "lung-heart-brain" multi-organ axis. PLACO identified 94 pleiotropic SNPs, with consistent colocalization signals at 15q25.1 (CHRNA3/5, IREB2) and 4q22 (SOX7). SMR analysis further prioritized 626 candidate genes, including ZNF652, XRCC3, SLC22A5, and SOX7, which may serve as potential therapeutic targets. Conclusion: This study provides genetic evidence for shared mechanisms linking COPD with HTN, CHD, and HF. It highlights the roles of neurotransmitter receptors, iron metabolism, vascular development, and energy metabolism in COPD-CVD comorbidity. These findings offer insights into precision prevention and therapeutic strategies targeting COPD-CVD comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.